The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation ...